Cell Care Therapeutics
Long Beach
About Cell Care Therapeutics
Cell Care Therapeutics is a Los Angeles based preclinical stage company developing regenerative immunotherapies. This new class of biologics is derived from the secretions of adult stem cells and is comprised of a complex mixture of naturally therapeutic components including proteins, exosomes, and microRNAs. Cell Care has formed a strong team of internal scientists, world class advisors, and manufacturing experts to advance this technology into the clinic. This team has established scalable manufacturing approaches for production of the secretome product and has made great progress in developing the secretome as a platform technology. The company is currently developing this technology to treat severe inflammatory and degenerative eye diseases that may lead to vision loss.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.3M
- Funding stage: Seed
- Last round: Seed (Oct 2018)
- Website: cell-care.com
- Phone: (562) 528-3120
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cell-care-therapeutics-10337 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.